These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35113892)

  • 1. Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.
    Jolayemi O; Bogart LM; Storholm ED; Goodman-Meza D; Rosenberg-Carlson E; Cohen R; Kao U; Shoptaw S; Landovitz RJ
    PLoS One; 2022; 17(2):e0262926. PubMed ID: 35113892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting injectable ART to advance health equity: a descriptive analysis of US clinic perspectives on barriers, needed support and programme goals for implementation from applications to the ALAI UP Project.
    Nguyen N; Lane B; Golub SA; Chastain C; Zucker J; King K; Terry M; Burdge J; Carnevale C; Muscarella A; Castor D; Kutner B; Meyers K
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26282. PubMed ID: 38965977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States.
    McCrimmon T; Collins LF; Perez-Brumer A; Bazzi AR; Shaffer VA; Kerrigan D; Alcaide ML; Philbin MM
    AIDS Patient Care STDS; 2024 Feb; 38(2):61-69. PubMed ID: 38381949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives.
    Koester KA; Colasanti JA; McNulty MC; Dance K; Erguera XA; Tsuzuki MD; Johnson MO; Sauceda JA; Montgomery E; Schneider J; Christopoulos KA
    Implement Sci Commun; 2023 Oct; 4(1):128. PubMed ID: 37858272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida.
    Fisk-Hoffman RJ; Ranger SS; Gracy A; Gracy H; Manavalan P; Widmeyer M; Leeman RF; Cook RL; Canidate S
    AIDS Patient Care STDS; 2024 Jun; 38(6):275-285. PubMed ID: 38686517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda.
    Kennedy CE; Zhao T; Vo AV; Nakubulwa R; Nabakka P; Jackson J; Rosen JG; Chang LW; Reynolds SJ; Quinn TC; Nakigozi G; Kigozi G; Kagaayi J; Nalugoda F; Ddaaki WG; Grabowski MK; Nakyanjo N
    AIDS Patient Care STDS; 2023 Jun; 37(6):316-322. PubMed ID: 37294280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia.
    Xavier Hall CD; Smith JC; Driggers RA; Stoller B; Khan Z; Li J; Ignatius EH; Siegler AJ
    AIDS Care; 2021 Jun; 33(6):706-711. PubMed ID: 32838546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study.
    Rutstein SE; Sibley AL; Huffstetler HE; Nguyen TTD; Tran HV; Le Minh G; Sripaipan T; Nguyen M; Miller WC; Eron JJ; Gay CL; Go VF
    Lancet Reg Health West Pac; 2023 Feb; 31():100603. PubMed ID: 36879789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island.
    Collins AB; Macon EC; Langdon K; Joseph R; Thomas A; Dogon C; Beckwith CG
    J Urban Health; 2023 Oct; 100(5):1062-1073. PubMed ID: 37563518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "I Feel Like I Don't Even Have HIV Anymore"-Facilitators, Barriers, and Experience regarding Use of Long-Acting Injectable Antiretroviral Therapy Among Persons with HIV in North Carolina.
    Agarwal H; Huffstetler HE; Lopez C; Go VF; Napravnik S; Farel CE; Rutstein SE
    AIDS Patient Care STDS; 2024 Jul; 38(7):324-329. PubMed ID: 38860413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South.
    Campbell CK; Kielhold K; Reynolds HE; Vincent W; Siconolfi DE; Ramos SD; Ogunbajo A; Kegeles SM; Storholm ED
    Int J Environ Res Public Health; 2024 May; 21(5):. PubMed ID: 38791816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.
    Philbin MM; Parish CL; Kinnard EN; Reed SE; Kerrigan D; Alcaide ML; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Metsch LR
    J Acquir Immune Defic Syndr; 2020 Jul; 84(3):263-270. PubMed ID: 32530905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States.
    Erguera XA; Koester KA; Diaz Tsuzuki M; Dance KV; Flores R; Kerman J; McNulty MC; Colasanti JA; Collins LF; Montgomery ET; Johnson MO; Sauceda JA; Christopoulos KA
    AIDS Behav; 2024 Jul; 28(7):2226-2238. PubMed ID: 38598026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York.
    Irvine MK; Zimba R; Avoundjian T; Peterson M; Emmert C; Kulkarni SG; Philbin MM; Kelvin EA; Nash D
    JMIR Res Protoc; 2024 Mar; 13():e56892. PubMed ID: 38536227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use.
    Philbin MM; Parish C; Bergen S; Kerrigan D; Kinnard EN; Reed SE; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Alcaide ML; Metsch LR
    AIDS Patient Care STDS; 2021 Jan; 35(1):23-30. PubMed ID: 33400587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review.
    Kanazawa JT; Saberi P; Sauceda JA; Dubé K
    AIDS Res Hum Retroviruses; 2021 Feb; 37(2):75-88. PubMed ID: 33176429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain.
    Moreno C; Izquierdo R; Alejos B; Hernando V; Pérez de la Cámara S; Peraire J; Macías J; Bernal E; Albendín-Iglesias H; Alcaraz B; Suárez-García I; Moreno S; Jarrín I;
    AIDS Patient Care STDS; 2024 Jul; 38(7):305-314. PubMed ID: 38916077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Patient Decision Aid (i.ARTs) to Facilitate Women's Choice Between Oral and Long-Acting Injectable Antiretroviral Treatment for HIV: Protocols for its Development and Randomized Controlled Pilot Trial.
    Philbin MM; McCrimmon T; Shaffer VA; Kerrigan D; Pereyra M; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Topper EF; Rana A; Tamraz B; Goparaju L; Wilson TE; Alcaide M
    JMIR Res Protoc; 2022 Sep; 11(9):e35646. PubMed ID: 36099004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.
    Mantsios A; Murray M; Karver TS; Davis W; Galai N; Kumar P; Swindells S; Bredeek UF; García RR; Antela A; Gomis SC; Bernáldez MP; Czarnogorski M; Hudson K; Walters N; Kerrigan D
    BMC Health Serv Res; 2021 Mar; 21(1):255. PubMed ID: 33743684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most.
    Philbin MM; Bergen S; Parish C; Kerrigan D; Kinnard EN; Reed S; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Vaughn M; Gutierrez JI; Fischl MA; Alcaide M; Metsch LR
    AIDS Behav; 2022 Apr; 26(4):1260-1269. PubMed ID: 34648131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.